HealthcareServices

Revenue of the Cryptococcosis Market Predicted to Achieve $10.8 Billion by 2030, Driven by 8.8% CAGR

February 23, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cryptococcosis market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Cryptococcosis Market by the end of 2030?

The cryptococcosis market has experienced significant expansion in recent years. Its size is projected to increase from $7.07 billion in 2025 to $7.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. The historical progression of this market can be attributed to factors such as a high hiv aids prevalence, increasing organ transplant procedures, limited early diagnostic capabilities, a reliance on amphotericin b therapy, and hospital-centered infection management.

The cryptococcosis market is projected to experience substantial expansion in the coming years. This market is predicted to reach $10.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. Several factors are expected to drive this growth during the forecast period, including advancements in fungal diagnostics, a growing immunocompromised population, increased recognition of cryptococcal meningitis, the creation of safer antifungal treatments, and enhanced availability of healthcare services. Key trends anticipated within the forecast period encompass a heightened emphasis on the early detection of fungal infections, greater adoption of combination antifungal therapies, more rigorous monitoring of immunocompromised individuals, the expansion of hospital-centric fungal care, and improved accessibility to molecular diagnostic techniques.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21929&type=smp

What Drivers Are Shaping Future Opportunities In The Cryptococcosis Market?

The increasing occurrence of respiratory infections is expected to boost the growth of the cryptococcosis market in the coming years. Respiratory infections are conditions that affect parts of the respiratory system, such as the nose, throat, airways, and lungs, and can be caused by viruses, bacteria, or fungi. The prevalence of these infections is rising partly due to air pollution, where substances like smoke, dust, and chemicals damage lung function, making individuals more vulnerable to illnesses. A weakened immune system creates favorable conditions for opportunistic diseases like cryptococcosis to thrive. This fungal infection mainly impacts the lungs and central nervous system, presenting significant risks, especially for immunocompromised people. For example, in December 2024, the Australian Bureau of Statistics, an Australian government agency, reported that influenza-related deaths increased in 2024, with 951 recorded deaths, up from 427 deaths in 2022. Thus, the growing incidence of respiratory infections is propelling the cryptococcosis market forward.

Which Segments Are Gaining Traction In The Cryptococcosis Market?

The cryptococcosis market covered in this report is segmented –

1) By Treatment Type: Adjunctive Therapies, Antifungal Drugs

2) By Diagnostic Technique: Culture Methods, Microscopic Examination, Molecular Methods

3) By Infection Type: Cerebral Cryptococcosis, Pulmonary Cryptococcosis

4) By End User: Clinics, Home Healthcare, Hospitals, Research Institutes

Subsegments:

1) By Adjunctive Therapies: Immunotherapy, Surgery, Supportive Care

2) By Antifungal Drugs: Amphotericin B, Fluconazole, Itraconazole, Voriconazole

What Trends Are Driving The Growth Trajectory Of The Cryptococcosis Market?

Key entities active within the cryptococcosis market are diligently conducting clinical trials aimed at devising safer and more efficacious antifungal therapies. These trials are crucial for assessing novel treatments and enhancing outcomes for individuals afflicted with severe fungal infections. As an illustration, in August 2023, Matinas BioPharma Holdings Inc., a US-based biopharmaceutical company in the clinical stage, revealed positive findings from its Phase II EnACT trial, which focused on evaluating MAT2203 for managing cryptococcal meningitis. MAT2203 is an oral lipid nanocrystal formulation of amphotericin B that specifically targets fungal cell membranes, thereby disrupting their structure and leading to fungal cell death. The investigation showed improved patient survival rates and a favorable safety profile, emphasizing its potential as a pioneering treatment for cryptococcosis, including cryptococcal meningitis.

Who Are The Core Companies Influencing Trends In The Cryptococcosis Market?

Major companies operating in the cryptococcosis market are Pfizer Inc, Johnson & Johnson, Merck and Co Inc, Abbott Laboratories, Gilead Sciences Inc, Asahi Kasei Pharma Corporation, Viatris Inc, Astellas Pharma Inc, Bausch Health Companies Inc, Sun Pharmaceutical Industries Ltd, Cipla Limited, Dr Reddys Laboratories, Century Pharmaceuticals Ltd, Beijing Lunarsun Pharmaceutical Co Ltd, Matinas Biopharma Holdings Inc, LGM Pharma, Atom Pharma, Brundavan Laboratories Pvt Ltd, Amar Healthcare, Novartis AG, Sanofi SA, Bristol Myers Squibb, Teva Pharmaceutical Industries Ltd, Lupin Limited, Glenmark Pharmaceuticals Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cryptococcosis-global-market-report

Which Regions Are Projected To Dominate The Cryptococcosis Market In The Coming Years?

North America was the largest region in the cryptococcosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cryptococcosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cryptococcosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21929&type=smp

Browse Through More Reports Similar to the Global Cryptococcosis Market 2026, By The Business Research Company

Nontuberculous Mycobacterial Infection Market Report 2026

https://www.thebusinessresearchcompany.com/report/nontuberculous-mycobacterial-infection-global-market-report

Crypto Wallet Market Report 2026

https://www.thebusinessresearchcompany.com/report/crypto-wallet-global-market-report

Cephalosporin Market Report 2026

https://www.thebusinessresearchcompany.com/report/cephalosporin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795